These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. DNase I and chitosan enhance efficacy of ceftazidime to eradicate Burkholderia pseudomallei biofilm cells. Pakkulnan R; Thonglao N; Chareonsudjai S Sci Rep; 2023 Jan; 13(1):1059. PubMed ID: 36658182 [TBL] [Abstract][Full Text] [Related]
9. Disruption of the Burkholderia pseudomallei two-component signal transduction system BbeR-BbeS leads to increased extracellular DNA secretion and altered biofilm formation. Alwis PA; Treerat P; Gong L; Deveson Lucas D; Allwood EM; Prescott M; Devenish RJ; Adler B; Boyce JD Vet Microbiol; 2020 Mar; 242():108603. PubMed ID: 32122607 [TBL] [Abstract][Full Text] [Related]
10. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation. Taweechaisupapong S; Kaewpa C; Arunyanart C; Kanla P; Homchampa P; Sirisinha S; Proungvitaya T; Wongratanacheewin S Microb Pathog; 2005 Sep; 39(3):77-85. PubMed ID: 16084684 [TBL] [Abstract][Full Text] [Related]
11. Quorum Sensing Influences Burkholderia thailandensis Biofilm Development and Matrix Production. Tseng BS; Majerczyk CD; Passos da Silva D; Chandler JR; Greenberg EP; Parsek MR J Bacteriol; 2016 Oct; 198(19):2643-50. PubMed ID: 27068594 [TBL] [Abstract][Full Text] [Related]
12. Correlation between biofilm production, antibiotic susceptibility and exopolysaccharide composition in Burkholderia pseudomallei bpsI, ppk, and rpoS mutant strains. Mongkolrob R; Taweechaisupapong S; Tungpradabkul S Microbiol Immunol; 2015 Nov; 59(11):653-63. PubMed ID: 26486518 [TBL] [Abstract][Full Text] [Related]
13. Biomarker discovery in the biofilm-forming process of Burkholderia pseudomallei by mass-spectrometry. Hadpanus P; Permsirivisarn P; Roytrakul S; Tungpradabkul S J Microbiol Methods; 2019 Apr; 159():26-33. PubMed ID: 30797019 [TBL] [Abstract][Full Text] [Related]
14. Nitrate Sensing and Metabolism Inhibit Biofilm Formation in the Opportunistic Pathogen Mangalea MR; Plumley BA; Borlee BR Front Microbiol; 2017; 8():1353. PubMed ID: 28790983 [TBL] [Abstract][Full Text] [Related]
15. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis. Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506 [TBL] [Abstract][Full Text] [Related]
16. Role of Burkholderia pseudomallei biofilm formation and lipopolysaccharide in relapse of melioidosis. Limmathurotsakul D; Paeyao A; Wongratanacheewin S; Saiprom N; Takpho N; Thaipadungpanit J; Chantratita N; Wuthiekanun V; Day NP; Peacock SJ Clin Microbiol Infect; 2014 Nov; 20(11):O854-6. PubMed ID: 24602145 [TBL] [Abstract][Full Text] [Related]
17. The NarX-NarL two-component system regulates biofilm formation, natural product biosynthesis, and host-associated survival in Burkholderia pseudomallei. Mangalea MR; Borlee BR Sci Rep; 2022 Jan; 12(1):203. PubMed ID: 34997073 [TBL] [Abstract][Full Text] [Related]
18. In silico prediction of host-pathogen protein interactions in melioidosis pathogen Burkholderia pseudomallei and human reveals novel virulence factors and their targets. Loaiza CD; Duhan N; Lister M; Kaundal R Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32444871 [TBL] [Abstract][Full Text] [Related]
19. Effect of fluoxetine on planktonic and biofilm growth and the antimicrobial susceptibility of Guedes GM; Araújo ES; Ribeiro KV; Pereira VC; Soares AC; Freitas AS; Amando BR; Cordeiro RA; Rocha MF; Sidrim JJ; Castelo-Branco DS Future Microbiol; 2023 Aug; 18():785-794. PubMed ID: 37622278 [No Abstract] [Full Text] [Related]
20. Burkholderia pseudomallei resistance to antibiotics in biofilm-induced conditions is related to efflux pumps. Sirijant N; Sermswan RW; Wongratanacheewin S J Med Microbiol; 2016 Nov; 65(11):1296-1306. PubMed ID: 27702426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]